What Changed
Price Move History
- Daily moves over 5%
- 158 226 sessions, September 22, 2025 to September 22, 2026
- Largest daily move
- +1011.1% close of September 22, 2026
- 1-year change
- -6.5% closing prices, September 22, 2025 to September 22, 2026
Company Description
UNIVERSAL IBOGAINE (OTC: IBOGF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.2M.
IBOGF has declined 6.5% over the past year. The last closing price was $0.0100.
This page collects what Stock Titan holds for IBOGF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
UNIVERSAL IBOGAINE (IBOGF) closed at $0.0100 on September 22, 2026. Over the past 12 months, the price has lost 6.5%.
IBOGF Metrics & Rankings
Price returns through September 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
UNIVERSAL IBOGAINE has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all IBOGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in UNIVERSAL IBOGAINE (IBOGF) currently stands at 90.3 thousand shares, up 739.4% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 52.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for UNIVERSAL IBOGAINE (IBOGF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
IBOGF Company Profile & Sector Positioning
UNIVERSAL IBOGAINE (IBOGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IBOGF often look at related companies in the same sector, including DOSEOLOGY SCIENCES INC (DOSEF), BSF ENTERPRISE PLC (BSFAF), ASEP MEDICAL HOLDINGS INC (SEPSF), CORE ONE LABS INC (CLABF), and ORGENESIS INC (ORGS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IBOGF's relative position within its industry.